top of page
NEWS & EVENTS

Sep 23, 2022

Jun 20, 2022
Onward Therapeutics Made a Second Strategic Equity Investment in Emercell for Their NK Cell Technology in Cancer Immunotherapy
Read More...

Jun 08, 2021
Onward Therapeutics Signs an Exclusive Collaboration and Worldwide Option and License Agreement with Institut du Cancer de Montpellier
Read More...

May 04, 2021
Onward Therapeutics SA opened a wholly owned affiliate, Onward Therapeutics France SAS in Paris, France
Read More...

Feb 17, 2021
Onward Therapeutics Makes a Strategic Investment in EMERCell for Their NK Cell Technology for Immunotherapy
Read More...
bottom of page